BOS 0.00% 1.5¢ biosignal limited

more agreements, page-3

  1. 10,009 Posts.
    Yeah this is shaping up gto be a very interesting company. This list of potential uses for this technology is huge. What I particularly like about their approch is non exclusive licenses and plenty of deals. Most other bios with good platform technologies pick on use and plod away for years on only one aspect. BOS is out their to do the deals and get the money back in. Seems like one of the very few who have a strong commercial focus.
 
watchlist Created with Sketch. Add BOS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.